{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:14:25Z","timestamp":1784315665336,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.clinthera.2008.05.007","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T04:54:58Z","timestamp":1213419298000},"page":"813-824","source":"Crossref","is-referenced-by-count":40,"title":["Rotigotine transdermal system for the treatment of Parkinson's disease"],"prefix":"10.1016","volume":"30","author":[{"given":"David Q.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nogid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2008.05.007_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.56.suppl_5.S1","article-title":"An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines","volume":"56","author":"Olanow","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.05.007_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.007_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2165\/00023210-200519110-00006","article-title":"Rotigotine: In Parkinson's disease","volume":"19","author":"Reynolds","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2008.05.007_bib4","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.007_bib5","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial","volume":"284","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.007_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-200060010-00007","article-title":"Ropinirole: A review of its use in the management of Parkinson's disease","volume":"60","author":"Matheson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2008.05.007_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00003088-199426020-00005","article-title":"Pharmacokinetic characterisation of transdermal delivery systems","volume":"26","author":"Berner","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.05.007_bib8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1212\/WNL.65.2_suppl_1.S11","article-title":"Clinical studies with transdermal rotigotine in early Parkinson's disease","volume":"65","author":"Poewe","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.05.007_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870090204","article-title":"N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease","volume":"9","author":"Belluzzi","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2008.05.007_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/00023210-200721120-00007","article-title":"Rotigotine transdermal patch: A review of its use in the management of Parkinson's disease","volume":"21","author":"Baldwin","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2008.05.007_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00702-007-0719-3","article-title":"Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation","volume":"114","author":"Kehr","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.clinthera.2008.05.007_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/FBP.0b013e3280ebb400","article-title":"Plasma levels of rotigotine and the reversal of motor deficits in MPTPtreated primates","volume":"18","author":"Rose","year":"2007","journal-title":"Behav Pharmacol"},{"issue":"Suppl 8","key":"10.1016\/j.clinthera.2008.05.007_bib13","first-page":"S54","article-title":"Neuroprotection by rotigotine: Investigations in MPTP-lesioned mice under continuous dopaminergic stimulation","volume":"56","author":"Scheller","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.WNF.0000228179.83335.65","article-title":"Rotigotine transdermal patch enables rapid titration to effective doses in advanced-stage idiopathic Parkinson disease: Subanalysis of a parallel group, open-label, dose-escalation study","volume":"29","author":"Babic","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.wnf.0000162228.00154.ba","article-title":"Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson disease","volume":"28","author":"G\u00fcldenpfennig","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.64.5.676","article-title":"Transdermal rotigotine: Double-blind, placebo-controlled trial in Parkinson disease","volume":"64","author":"Jankovic","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002826-200105000-00008","article-title":"Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease","volume":"24","author":"Metman","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00003088-200746100-00003","article-title":"Transdermal administration of radiolabelled [14C]rotigotine by a patch formulation: A mass balance trial","volume":"46","author":"Cawello","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 15","key":"10.1016\/j.clinthera.2008.05.007_bib19","first-page":"S547","article-title":"Pharmacokinetics, safety, and tolerability of rotigotine after transdermal patch administration in Japanese and Caucasian healthy subjects","volume":"21","author":"Cawello","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2008.05.007_bib20","first-page":"1091","article-title":"Low drug-drug interaction potential of rotigotine","volume":"45","author":"Hansen","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib21","doi-asserted-by":"crossref","unstructured":"Neupro (rotigotine) transdermal patch [package insert]. Smyrna, Ga: UCB, Inc; 2006.","DOI":"10.3833\/pdr.v2006i67.580"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.05.007_bib22","first-page":"85","article-title":"Characteristics of rotigotine elimination after patch removal","volume":"13","author":"Cawello","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib23","unstructured":"Braun M, Cawello W, Poole K, Horstmann R. Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease. Poster presented at: 9th Congress of the European Federation of Neurological Societies; September17-20,2005;Athens,Greece. Abstract P1245."},{"key":"10.1016\/j.clinthera.2008.05.007_bib24","first-page":"1091","article-title":"Pharmacokinteics of transdermal tine transdermal rotigotine in subjects with impaired renal function","volume":"45","author":"Cawello","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870090112","article-title":"Unified kinson's Disease Rating Scale concharacteristics and structure","volume":"9","author":"Mart\u00efnez-Mart\u00efn","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2008.05.007_bib26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archneur.60.12.1721","article-title":"A controlled trial of rotigotine monoal, therapy in early Parkinson's disease","volume":"60","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2008.05.007_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.05.007_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mds.1085","article-title":"Transdermal dopaminergic D(2) receptor agonist theraphy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study","volume":"16","author":"Hutton","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2008.05.007_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"Advanced Parkinson disease treated with rotigotine transdermal system: PREFER study","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.05.007_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: A double-blind, double-dummy, randomised trolled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.05.007_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199855001-00004","article-title":"Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial","volume":"55","author":"Rinne","year":"1998","journal-title":"Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.05.007_bib32","first-page":"103","article-title":"Lack of pharmacokinetic interactions between the dopamine agonist rotigotine and levodopa\/carbidopa","volume":"11","author":"Braun","year":"2005","journal-title":"Parkinson Relat Disord"},{"key":"10.1016\/j.clinthera.2008.05.007_bib33","series-title":"Red Book UPDATE, August 2007","year":"2007"},{"key":"10.1016\/j.clinthera.2008.05.007_bib34","series-title":"Red Book: Pharmacy's Fundamental Reference","year":"2005"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T23:37:47Z","timestamp":1557617867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180800177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S014929180800177X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}